i was wrong about the compounding change taking effect immediately, it was phased, and i had told three people otherwise
#anz 2025-10-03
is it cheaper through a clinic or a pharmacy in australia
shipping into an australian summer, what do people actually do about it
insulated pouch, gel packs frozen solid, fastest leg you can buy. that is the whole summer protocol as this room has it, not advice obviously
[edited]coming back after 8 months, is supply any better in australia now
quick one i do not order between december and february. that is my own rule after a january parcel arrived warm and soft
any pricing in this channel is a snapshot from whenever it was typed. australian prices moved a lot in two years
as far as i understood it a year ago, the pbs listing covered the diabetes indication and not weight management, and that split catches people out
powder survived
is there a temperature controlled option worth paying for into australia
temperature controlled shipping into australia exists and the quote i got was more than the peptide
an australian summer transit is the worst cold chain problem discussed in this channel and it is not close
summer is the risk
nobody here can tell you what is allowed in australia and the mods will stop that conversation, thats just me
pbs is diabetes only afaik
pharmac in new zealand, has anything moved on funding
does anyone hold off ordering between december and february
the pharmacist i asked was straightforward about supply and had no idea about anything else, which is fair enough
Testing queue: 3 submissions open, 38 awaiting dispatch.
australian here, brand new. is any of this on the PBS or am i paying
for type 2 diabetes there is a subsidised path with criteria. for weight management, as of 2025, you are paying
paying how much
i was around AUD 460 a month at a mid dose in Melbourne last year, plus the script and the consult
similar in Sydney, slightly worse if you use a clinic that bundles a subscription on top
and TGA approval, thats separate from the PBS?
completely separate. TGA says it may be sold. the PBS decides whether the taxpayer contributes. those two answers do not have to agree and often dont
that distinction confuses more Australians than anything else in this channel
the New Zealand version of the same split is Medsafe approval versus Pharmac funding, and Pharmac funding for weight is simply not there
so we watch Australia complain about AUD 460 with a certain amount of feeling
whats it like in NZ then
private, unfunded, and supply here has been thinner than in Australia at several points. small market, we are not anyones priority
the small market problem is brutal and nobody outside NZ ever mentions it
Pharmac operates a fixed budget, so funding one thing means not funding another thing, out loud, in public. its more honest than most systems and it means slower
and a fixed budget means an incredibly hard bargain, which is why NZ sometimes gets very cheap things very late
the bigger change here was compounding
compounding?
there was a stretch where compounded versions were widely available through Australian clinics at maybe a third of the branded price
from around October 2024 the rules changed and that route effectively closed. a lot of people woke up with no supplier
i was one of them. two weeks notice, then nothing
what did you do
paid four times as much, quietly, and did not tell my partner for a month
very relatable and slightly grim
rough state of play as of 2025, corrections welcome, all member-reported
| Where | Diabetes indication | Weight indication | Typical private monthly | Notes |
|---|---|---|---|---|
| Australia | subsidised with criteria | not subsidised | AUD 420-560 | compounded route closed late 2024 |
| New Zealand | some funded options, criteria | not funded | NZD 500-700 | thin supply, small market |
| Australia (regional) | same on paper | same on paper | same plus freight | cold-chain freight is the real cost |
regional freight being a line item had not occurred to me
it should. see the summer shipping conversation, its its own nightmare
and as always, none of this is anyone telling you what to take. we are describing bills
the interesting comparison is that Australia and NZ both said no to funding weight management while both funding the diabetes indication
which is a policy statement about what obesity is, not a statement about the drug
thats it exactly and it is very tiring to live inside
back to TGA versus PBS — does TGA approval for weight make PBS listing more likely later
it is the necessary first step and it is nowhere near sufficient. the sponsor has to apply, and the cost-effectiveness case at these prices and this population size is enormous
translation: not soon
translation appreciated, hated